维普中文期刊产品整合服务
17篇 您的检索式:作者名="Porter RL"
    题名 作者 年代 出处 被引量
1Gallbladder absorption increase during early cholesterol gallstone formation显示文摘Conter RL Reslyn JJ Porter Fink V 1986Am J Surg1986,151,1:1
2Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lyric bone metastases显示文摘Hortobagyi GN Theriault RL Porter L 1996N Engl J Med1996,335,24:1
3In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells显示文摘Frisch BJ Porter RL Gigliotti BJ 2009Blood2009,114,19:1
4Perioperative ketamine for acute postoperative analgesia:the Mayo ClinicFlorida experience显示文摘Porter SB McClain RL Howe BL 2015J Perianesth Nurs2015,30,3:1
5Communications between bone cells and hem- atopoietic stem cells显示文摘Porter RL Calvi LM 2008Arch Biochem Biophys2008,473,2:1
6The isolation of sucrose-fermenting Salmonella mbandaka显示文摘Reid RL Porter RC Ball HJ 1993Vet Microbiol1993,37,12:1
7Efficacy of pamidranate in reducing skeletal complications in patients with breast cancer and lytic bone metastases显示文摘Hortobagyi GN Theriault RL Porter L 1996N Engl J Med1996,335,:1
8Second auto - SCT is safe and effectivesalvage therapy for relapsed multiple mye- loma显示文摘O/in RL Vogl DT Porter DL 2009Bone Marrow Transplant2009,43,:1
9Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases显示文摘Hortobagyi GN Theriault RL Porter L 1996N Engl J Med1996,335,:1
10Hematopoietic niche and bone meet显示文摘Frisch B J Porter RL Calvi LM 2008Curr Opin Support Palliat Care2008,2,3:1
11In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferential y expands short-term hematopoietic stem cel s显示文摘Frisch BJ Porter RL Gigliotti BJ 2009{H}Blood2009,,19:1
12Efficacy of pam-idranate in reducing skeletal complications in patients with breast cancer and lytic bone metastases显示文摘Hortobagyi GN Theriault RL Porter L 1996N Engl J Med1996,33,5:1
13Efficacy of pam idronate in reducing skeletal comp lications patients with breast cancer and lytlc bone metastases显示文摘Hortobagiv GN Theriault RL Porter L 2002N Engl J Med2002,35,:1
14Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases显示文摘Hortobagyi GN Theriault RL Porter l 1996N Engl J Med1996,335,8:1
15Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases 显示文摘Hortobagyi GN Theriauh RL Porter L 1996N Engl J Med1996,335,3:1
16Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases显示文摘Hortobagyi GN Theriault RL Porter L 1996N Engl J Med1996,335,24:1
17Gallbladder absorption increase during early cholesterol gallstone formation显示文摘Conter RL Roslyn JJ Porter Fink V 1986Am J Surg1986,151,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费